Mkts

Akari Therapeutics Plc

NASDAQ: AKTX
$6.80+0.29 (+4.45%)
As of Nov 13, 3:30 PM ET

Key statistics

Day range
6.527.55
52-week range
3.0229.32
Today
Open6.52
Previous close6.80
Volume53.1K
Valuation
Market cap11.40M
P/E ratio—
EPS (TTM)-0.00
Income & risk
Dividend / yield—
Beta1.52
Avg volume56.9K
Discussion

AKTX News

Stories mentioning AKTX from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue
Cost of Goods Sold
Gross Profit0.000.000.000.000.000.000.000.00
Operating Expenses
Research & Development1,4591,086249.00667.00813.001,247143.003,314
Sales General & Admin2,1692,1411,9752,4522,7122,0041,7092,241
Total Operating Expenses15,7583,525
Operating Income (Loss)(15,758)(3,227)(7,404)(3,119)(3,525)(5,278)(2,927)(7,449)
Interest Income1.001.003.002.00
Interest Expense100.0051.00
Other Expense
Pretax Income(15,314)(7,488)(3,705)(2,895)
Tax Provision(859.00)85.00(1,088)0.000.00
Net Income (Loss)(14,455)(5,298)(6,400)(1,895)(3,705)(3,772)(2,895)(7,558)
Earnings Per Share (Basic)0.000.000.000.000.000.000.000.00
Earnings Per Share (Diluted)0.000.000.000.000.000.000.000.00
Weighted Average Shares Outstanding (Basic)118,757,01367,328,12965,326,23762,943,89654,588,28423,888,01024,386,00618,836,479
Weighted Average Shares Outstanding (Diluted)118,757,01367,328,12965,326,23762,943,89654,588,28423,888,01024,386,00618,836,479

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About AKTX

Akari Therapeutics Plc (NASDAQ: AKTX) is a stock listed on the Nasdaq Stock Market under the ticker symbol AKTX. It last traded at $6.80 (Nov 13, 2026, 3:30 PM ET), up 4.5% on the day. That gives Akari Therapeutics a market capitalisation of $11.4M.

Over the past 52 weeks AKTX has traded between $3.02 and $29.32.

For the quarter ended Mar 31, 2026 it reported a net loss of $14.5M.

Last 4 quarters
Quarter endedRevenueNet income
Mar 31, 2026—-$14.5M
Dec 31, 2025—-$5.3M
Sep 30, 2025—-$6.4M
Jun 30, 2025—-$1.9M

From Akari Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…